Purchases and Sales Made in Q3 2023 in Intra Cellular Therapies, Inc. (ITCI)
This table provides information about the institutional ownership of Intra Cellular Therapies, Inc. (ITCI) during Q3 2023. The information is specifically focused on institutions that hold shares of Intra-Cellular Therapies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-225K- 98.14% |
$11.7M - $14.4M
|
4.26K
$354K
|
|
|
Nov 14, 2023
Q3 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-247K- 25.7% |
$12.8M - $15.8M
|
713K
$59.3M
|
|
|
Nov 14, 2023
Q3 2023
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-263K- 15.53% |
$13.7M - $16.9M
|
1.43M
$119M
|
|
|
Nov 13, 2023
Q3 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-641K- 49.56% |
$33.4M - $41.1M
|
652K
$54.2M
|
|
|
Oct 07, 2024
Q3 2023
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-641K- 49.56% |
$33.4M - $41.1M
|
652K
$54.2M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-863KClosed |
$45M - $55.3M
|
0
$0
|